Amylyx Pharmaceuticals EPS AMLX

Diluted earnings per share by quarter and over the last twelve months, from 2021.

Amylyx Pharmaceuticals' earnings per share was −$1.43 over the twelve months to Jun 30, 2026.

In its latest quarter, Q2 FY26, it was −$0.39.

Earnings per share over time

Each fiscal year is the twelve months to its fourth quarter.

Quarter	Ended	EPS	On a year earlier	Last 12 months
Q2 FY26	Jun 30, 2026	−$0.39	n/a	−$1.43
Q1 FY26	Mar 31, 2026	−$0.37	n/a	−$1.50
Q4 FY25	Dec 31, 2025	−$0.30	n/a	−$1.55
Q3 FY25	Sep 30, 2025	−$0.37	n/a	−$1.80
Q2 FY25	Jun 30, 2025	−$0.46	n/a	−$2.50
Q1 FY25	Mar 31, 2025	−$0.42	n/a	−$3.11
Q4 FY24	Dec 31, 2024	−$0.55	−886%	−$4.44
Q3 FY24	Sep 30, 2024	−$1.07	−457%	−$3.82
Q2 FY24	Jun 30, 2024	−$1.07	−445%	−$2.45
Q1 FY24	Mar 31, 2024	−$1.75	−8850%	−$1.07
Q4 FY23	Dec 31, 2023	$0.07	n/a	$0.70
Q3 FY23	Sep 30, 2023	$0.30	n/a	−$0.02

Companies in Drug Manufacturers - General nearest Amylyx Pharmaceuticals' size, closest first, today.

Company	EPS, 12 months	Growth
AMLXAmylyx Pharmaceuticals	−$1.43
NRIXNurix Therapeutics	$2.31
OGNOrganon	$0.77	−71% a year
LQDALiquidia	$1.39
ARQTArcutis Biotherapeutics	$0.22
PBHPrestige Consumer Healthcare	$3.57	−16% a year
INDVIndivior Pharmaceuticals	$2.78	+227% a year
HRMYHarmony Biosciences	$3.09	−0% a year
ANIPANI Pharmaceuticals	$4.70
PAHCPhibro Animal Health	$2.44	+107% a year
KNSAKiniksa Pharmaceuticals International	$0.97	+2325% a year
Peer median	$2.38